1. Home
  2. ICHR vs NBTX Comparison

ICHR vs NBTX Comparison

Compare ICHR & NBTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ichor Holdings

ICHR

Ichor Holdings

HOLD

Current Price

$96.71

Market Cap

1.6B

Sector

Technology

ML Signal

HOLD

Logo Nanobiotix S.A.

NBTX

Nanobiotix S.A.

HOLD

Current Price

$41.78

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ICHR
NBTX
Founded
1999
2003
Country
United States
France
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.8B
IPO Year
2016
2018

Fundamental Metrics

Financial Performance
Metric
ICHR
NBTX
Price
$96.71
$41.78
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
1
Target Price
$49.50
$36.00
AVG Volume (30 Days)
1.3M
73.6K
Earning Date
05-04-2026
03-31-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$947,652,000.00
N/A
Revenue This Year
$20.51
$58.17
Revenue Next Year
$17.08
N/A
P/E Ratio
N/A
N/A
Revenue Growth
11.61
N/A
52 Week Low
$13.15
$4.93
52 Week High
$113.58
$57.14

Technical Indicators

Market Signals
Indicator
ICHR
NBTX
Relative Strength Index (RSI) 56.53 61.91
Support Level $60.40 $30.15
Resistance Level N/A $57.14
Average True Range (ATR) 8.36 2.53
MACD 0.41 0.74
Stochastic Oscillator 38.66 91.43

Price Performance

Historical Comparison
ICHR
NBTX

About ICHR Ichor Holdings

Ichor Holdings Ltd designs, engineers, and manufactures critical fluid delivery subsystems and components mainly for semiconductor capital equipment, along with solutions for defense/aerospace and medical industries. Its product portfolio includes gas and chemical delivery subsystems that enable precise delivery, monitoring, and control of specialized gases and reactive liquid chemistries used in semiconductor manufacturing processes such as etch, electroplating, and cleaning. The company also provides precision-machined components, weldments, e-beam and laser-welded components, as well as precision vacuum and hydrogen brazing. Geographically, the company operates across the United States, Singapore, Europe, and other regions, with Singapore contributing the majority of revenue.

About NBTX Nanobiotix S.A.

Nanobiotix SA is a late-stage clinical biotechnology company focused on re-inventing medicine by building new therapies atom by atom, developing widely applicable, first-in-class, physics-based nanotherapeutics to transform treatment outcomes and expand life for millions of patients. The objective of this physics-based approach is to allow nanoparticles to be combined with other drugs or therapeutic modalities and to integrate seamlessly into clinical practice without adding burden for the patient, healthcare provider, or healthcare system. It has three platforms Nanoradioenhancer platform: Nanoprimer platform: and Neurological disease platform. It has one segment, which is the research and development of product candidates that use proprietary nanotechnology to transform cancer treatment.

Share on Social Networks: